THNR vs. JDOC ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to JPMorgan Healthcare Leaders ETF (JDOC)

THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$26.64

Average Daily Volume

3,146

Number of Holdings ^*

6

* may have additional holdings in another (foreign) market

JDOC

JPMorgan Healthcare Leaders ETF

JDOC Description

The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.

Grade (RS Rating)

Last Trade

$60.40

Average Daily Volume

491

Number of Holdings ^*

8

* may have additional holdings in another (foreign) market

Performance

Period	THNR	JDOC
30 Days	-5.52%	-4.87%
60 Days	2.66%	0.23%
90 Days	2.87%	4.79%
12 Months

3 Overlapping Holdings

	Symbol	Grade	Weight in THNR	Weight in JDOC	Overlap
	LLY	D	14.78%	9.87%	9.87%
	NVO	F	12.82%	5.75%	5.75%
	TMO	C	4.91%	4.72%	4.72%

THNR Overweight 3 Positions Relative to JDOC

	Symbol	Grade	Weight
	AZN	D	7.38%
	AMGN	D	5.12%
	PFE	D	4.78%

THNR Underweight 5 Positions Relative to JDOC

	Symbol	Grade	Weight
	UNH	B	-9.18%
	ABBV	A	-4.83%
	REGN	D	-4.26%
	DHR	B	-3.92%
	BSX	A	-2.9%

THNR: Top Represented Industries & Keywords

Industries: Drug Manufacturers - Major Biotechnology Diagnostics & Research

Keywords: Inflammation Neuroscience Pharmaceutical Products S&P 500 Depressive Disorder Hypertension Major Depressive Disorder Obesity Alzheimer's Disease Animal Health Asthma Biopharmaceutical Biotechnology Bipolar Disorder Cancer Cholesterol Clinic Diabetes Drugs Dysfunction

JDOC: Top Represented Industries & Keywords

Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Health Care Plans Medical Devices

Keywords: S&P 500 Analytical Instruments Asthma Atopic Dermatitis Autoimmune Disease Benign Prostatic Hyperplasia Biopharmaceutical Biotechnology Bone Cholesterol Depressive Disorder Diabetes Disease Growth Hormone Hyperplasia Inflammation Medicine Obesity Percutaneous Pharmaceutical Products